These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 10382036)

  • 1. [Pharmacokinetic interactions between fluoroquinolones and methylxanthines].
    Iakovlev VP; Iakovlev SV
    Antibiot Khimioter; 1999; 44(3):35-41. PubMed ID: 10382036
    [No Abstract]   [Full Text] [Related]  

  • 2. The effects of quinolones on xanthine pharmacokinetics.
    Robson RA
    Am J Med; 1992 Apr; 92(4A):22S-25S. PubMed ID: 1580270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Gyrase inhibitors. Central nervous side effects and inhibition of methylxanthine elimination].
    Harder S; Shah PM; Staib AH
    Dtsch Med Wochenschr; 1990 Feb; 115(7):270-3. PubMed ID: 2406120
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacokinetic interactions related to the chemical structures of fluoroquinolones.
    Mizuki Y; Fujiwara I; Yamaguchi T
    J Antimicrob Chemother; 1996 May; 37 Suppl A():41-55. PubMed ID: 8737124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug interactions with clinafloxacin.
    Randinitis EJ; Alvey CW; Koup JR; Rausch G; Abel R; Bron NJ; Hounslow NJ; Vassos AB; Sedman AJ
    Antimicrob Agents Chemother; 2001 Sep; 45(9):2543-52. PubMed ID: 11502527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions of fluoroquinolones with other drugs: mechanisms, variability, clinical significance, and management.
    Radandt JM; Marchbanks CR; Dudley MN
    Clin Infect Dis; 1992 Jan; 14(1):272-84. PubMed ID: 1571442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of single doses of rufloxacin on the disposition of theophylline and caffeine after single administration.
    Cesana M; Broccali G; Imbimbo BP; Crema A
    Int J Clin Pharmacol Ther Toxicol; 1991 Apr; 29(4):133-8. PubMed ID: 2071262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetic interaction between theophylline and a newly developed quinolone, NY-198.
    Kuzuya T; Takagi K; Apichartpichean R; Muraoka I; Nadai M; Hasegawa T
    J Pharmacobiodyn; 1989 Jul; 12(7):405-9. PubMed ID: 2593082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The toxicology of cocoa and methylxanthines: a review of the literature.
    Tarka SM
    Crit Rev Toxicol; 1982; 9(4):275-312. PubMed ID: 6765610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-drug interactions with fluoroquinolones.
    Marchbanks CR
    Pharmacotherapy; 1993; 13(2 Pt 2):23S-28S. PubMed ID: 8474934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of oral anticoagulants with methyl xanthines.
    Ammar HO; Ghorab M; el-Nahhas SA; Makram TS
    Pharmazie; 1997 Dec; 52(12):946-50. PubMed ID: 9442558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physiologically based pharmacokinetic (PBPK) modeling of caffeine and theophylline in neonates and adults: implications for assessing children's risks from environmental agents.
    Ginsberg G; Hattis D; Russ A; Sonawane B
    J Toxicol Environ Health A; 2004 Feb; 67(4):297-329. PubMed ID: 14713563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacokinetic interaction of fluoroquinolones and other drugs].
    Iakovlev VP
    Antibiot Khimioter; 1998; 43(7):36-44. PubMed ID: 9727166
    [No Abstract]   [Full Text] [Related]  

  • 14. A pharmacometric approach to investigate the impact of methylxanthine abstinence and caffeine consumption on CYP1A2 activity.
    Perera V; Gross AS; Forrest A; Landersdorfer CB; Xu H; Ait-Oudhia S; McLachlan AJ
    Drug Metab Dispos; 2013 Nov; 41(11):1957-66. PubMed ID: 23996078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Moxifloxacin--antimicrobial activity and pharmacokinetic properties].
    Iakovlev VP; Polushkina NR
    Antibiot Khimioter; 2002; 47(5):19-29. PubMed ID: 12365324
    [No Abstract]   [Full Text] [Related]  

  • 16. [Fluoroquinolones. Drug interactions].
    Rusu G; Dănilă G
    Rev Med Chir Soc Med Nat Iasi; 2000; 104(2):45-9. PubMed ID: 12089990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topology of the interactions pattern in pharmaceutically relevant polymorphs of methylxanthines (caffeine, theobromine, and theophiline): combined experimental (¹H-¹⁴N nuclear quadrupole double resonance) and computational (DFT and Hirshfeld-based) study.
    Latosińska JN; Latosińska M; Olejniczak GA; Seliger J; Žagar V
    J Chem Inf Model; 2014 Sep; 54(9):2570-84. PubMed ID: 25184363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potentiating effects of methylxanthines on teratogenicity of mitomycin C in mice.
    Nakatsuka T; Hanada S; Fujii T
    Teratology; 1983 Oct; 28(2):243-7. PubMed ID: 6417813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic aspects of caffeine in premature infants.
    De Carolis MP; Romagnoli C; Muzii U; Tortorolo G; Chiarotti M; De Giovanni N; Carnevale A
    Dev Pharmacol Ther; 1991; 16(3):117-22. PubMed ID: 1914785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative pharmacokinetics of lomefloxacin and other fluoroquinolones].
    Iakovlev VP
    Antibiot Khimioter; 1998; 43(10):46-52. PubMed ID: 9825111
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.